Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.
about
Multifunctional iron platinum stealth immunomicelles: targeted detection of human prostate cancer cells using both fluorescence and magnetic resonance imagingPSMA ligand conjugated PCL-PEG polymeric micelles targeted to prostate cancer cells'Image and treat': an individualized approach to urological tumorsGCPII imaging and cancer.64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.A targeted low molecular weight near-infrared fluorescent probe for prostate cancer.Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imagingProstate specific membrane antigen- a target for imaging and therapy with radionuclides.Prostate-cancer-targeted N-(2-hydroxypropyl)methacrylamide copolymer/docetaxel conjugates.Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells.Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometryFunctional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cellsGlutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerProstate-specific membrane antigen-based imaging.Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment.In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer.Metal-Based PSMA Radioligands.Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysisPSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.
P2860
Q24634139-F9A2BF3D-0635-4DF2-BF2E-CD7FC693D303Q28544848-27C73B66-8B3B-4FF4-AF49-4284DBE764EBQ33792596-69C5335A-22C3-427F-BE42-049A0708E412Q33827632-9D985054-83AB-4C66-8542-8F2D1AA25618Q34458153-BE27DD14-DCC7-4265-A2F2-BB6457E5672FQ35446801-82D78DCC-2E98-4935-8770-C0AA81D3DE79Q36125199-5835973E-58EA-444C-8F37-D701E1A7E9ACQ36135685-4CDA3B03-3707-400E-A79F-D77ABA4B640FQ36160805-7B03C5F1-207A-4608-BCD2-CFFF550C63ADQ36279293-4B533E6B-CDC3-4F0F-998D-0A40E0B56874Q36962425-7B96CEF0-E6EE-4F08-9D38-FC0DC6A772A2Q37591940-512C8E75-C5EA-4C82-88CC-33EB24D781E8Q37972920-4BA3B2D0-FEA5-4177-9A79-D8394CFD066AQ38015617-2F13DB4B-897F-455A-A66D-97E8F525CCFAQ38167022-4C81E61A-AC5C-4609-BC42-CEA92F998D56Q38896408-FE94BD98-E436-48D9-969F-ABA79DB6FF47Q38955091-C4B9069A-82E9-44E4-8C64-87A38BA71442Q39198527-FCAF9A01-76FA-433F-ABE1-13E9461A09F7Q41192097-26025417-DBC8-42B0-AA69-3CC5022EC525Q41273648-78310503-EE25-4D02-8129-8BD96D5BCFB0
P2860
Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Three conformational antibodie ...... tic tools for prostate cancer.
@en
Three conformational antibodie ...... tic tools for prostate cancer.
@nl
type
label
Three conformational antibodie ...... tic tools for prostate cancer.
@en
Three conformational antibodie ...... tic tools for prostate cancer.
@nl
prefLabel
Three conformational antibodie ...... tic tools for prostate cancer.
@en
Three conformational antibodie ...... tic tools for prostate cancer.
@nl
P2093
P356
P1433
P1476
Three conformational antibodie ...... utic tools for prostate cancer
@en
P2093
Nikolaus Freudenberg
Patrick Bühler
Ulrich Wetterauer
Ursula Elsässer-Beile
Wolfgang Schultze-Seemann
P304
P356
10.1002/PROS.21090
P577
2010-04-01T00:00:00Z